Clinical trial Recruiting at 1 site Observational Ages 18 and up

Real-world cardiometabolic protection outcomes

Official title: REal-world Data of CARdiometabolic ProtEcTion

Run by Sun Yat-sen University · NCT07038083 · Data updated 2026-11-12

This project will test whether common cardiometabolic risk factors predict death and major heart-related events in adults with hypertension, diabetes, obesity, dyslipidemia, or high uric acid.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment40000 (estimated)
SponsorSun Yat-sen University
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedJanuary 1, 2014
Main results expectedJanuary 1, 2044
Study endsJanuary 1, 2044
Registry record updatedJune 26, 2025
Trial IDNCT07038083 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older treated at the First Affiliated Hospital of Sun Yat-sen University with a clinical diagnosis of hypertension, diabetes, overweight/obesity, dyslipidemia, or hyperuricemia are ideal candidates.

Probably not a fit

People without cardiometabolic conditions, those under 18, or patients treated exclusively outside the enrolling hospital with no accessible records are unlikely to benefit from this project.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center, historical prospective cohort uses clinical records from the First Affiliated Hospital of Sun Yat-sen University to follow adults diagnosed with cardiometabolic conditions. Eligible patients are those aged 18 or older with diagnoses such as hypertension, diabetes, overweight/obesity, dyslipidemia, or hyperuricemia based on standard clinical criteria. The primary outcomes are all-cause death and cardiovascular death, and the secondary outcome is major adverse cardiovascular events (MACE). The study will measure associations between established or suspected cardiometabolic risk factors and these outcomes in a real-world representative cohort.

Why it matters

Potential benefit: If successful, the findings could help clinicians identify which cardiometabolic risk factors most strongly predict death or major heart events and better target prevention and management.

How similar studies have gone: Large cohort studies have previously linked cardiometabolic risk factors to mortality and cardiovascular events, so this work seeks to confirm and refine those associations in a real-world Chinese hospital cohort.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients over 18 years old;
* Patients with clinical diagnosis of metabolic cardiovascular disease, including hypertension, diabetes, obesity, dyslipidemia, hyperuricemia.

  1. Hypertension and normal high blood pressure: Three standardized blood pressure measurements in the clinic on different days, and all the blood pressure values of the three measurements were systolic blood pressure ≥ 120 mmHg and/or diastolic blood pressure ≥ 80 mmHg;
  2. Diabetes: ① Typical symptoms of diabetes, and any of the following: ② Random blood glucose ≥ 11.1 mmol/L; ③ Fasting blood glucose (FPG) ≥ 7.0 mmol/L; ④ OGTT 2-hour postprandial blood glucose ≥ 11.1 mmol/L; ⑤ HbA1c ≥ 6.5%;
  3. Obesity and overweight: Body mass index (BMI) ≥ 24 kg/m²;
  4. Dyslipidemia: At least one of the following lipid indicators is abnormal: ① Total cholesterol (TC) ≥ 6.2 mmol/L; ② Low-density lipoprotein cholesterol (LDL-C) ≥ 4.1 mmol/L; ③ High-density lipoprotein cholesterol (HDL-C) \< 1.0 mmol/L; ④ Triglyceride (TG) ≥ 2.3 mmol/L; ⑤ Lipoprotein(a) ≥ 30 mg/dL;
  5. Hyperuricemia: The fasting blood uric acid levels on two different days were \> 420 μmol/L (7 mg/dL) in men and \> 360 μmol/L (6 mg/dL) in women.

Exclusion Criteria:

* Patients unable to provide informed consent.

Where it's running

  • The First Affiliated Hospital of Sun Yat-sen Univerity
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.